Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Muscarinic Agonist Modulation of Memory Processing Oscillatory Activity

NCT07228338 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT07228338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07228338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Muscarinic Agonist Modulation of Memory Processing Oscillatory Activity
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
December 31, 2031
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, mild, epilepsy, memory disorder, memory loss, seizures